Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Visentin

Showing results (51-60 of 193) with videos related to

Pageof 20
Sort By:
Haematologica|December 9, 2016
Peripheral neuropathies in chronic lymphocytic leukemia: a single center experience on 816 patientsChiara Briani, Andrea Visentin, Alessandro Salvalaggio, et al.
Annals of Hematology|May 6, 2018
Splenic marginal zone lymphoma with a de novo t(8;14)(q24;q32) and a prolymphocytoid evolution responsive to rituximab-bendamustineGreta Scapinello, Marco Pizzi, Stefania Vio, et al.
Hematological Oncology|August 16, 2018
Dabigatran in ibrutinib-treated patients with atrial fibrillation and lymphoproliferative diseases: Experience of 4 casesAndrea Visentin, Elena Campello, Edoardo Scomazzon, et al.
Current Oncology (Toronto, Ont.)|March 24, 2022
Primary Myelofibrosis Occurring during Targeted Therapy for Chronic Lymphocytic Leukemia: A Report of Two CasesFrancesco Angotzi, Andrea Visentin, Federico Scarmozzino, et al.
Frontiers in Oncology|April 8, 2022
Glycerophosphoinositol Promotes Apoptosis of Chronic Lymphocytic Leukemia Cells by Enhancing Bax Expression and ActivationGioia Boncompagni, Alessia Varone, Vanessa Tatangelo, et al.
Frontiers in Oncology|July 18, 2022
p66Shc Deficiency in Chronic Lymphocytic Leukemia Promotes Chemokine Receptor Expression Through the ROS-Dependent Inhibition of NF-κBVanessa Tatangelo, Gioia Boncompagni, Nagaja Capitani, et al.
Frontiers in Oncology|April 29, 2024
Efficacy and safety of venetoclax plus hypomethylating agents in relapsed/refractory acute myeloid leukemia: a multicenter real-life experienceFrancesco Angotzi, Federica Lessi, Matteo Leoncin, et al.
Hematological Oncology|July 4, 2023
The added value of karyotype in predicting the need for therapy in chronic lymphocytic leukemia with 13q deletionAnnalisa Martines, Angela Grassi, Andrea Visentin, et al.
Haematologica|April 8, 2017
Role of <i>miR-15a/miR-16-1</i> and the <i>TP53</i> axis in regulating telomerase expression in chronic lymphocytic leukemiaEnrica Rampazzo, Engin Bojnik, Livio Trentin, et al.
Hematological Oncology|May 13, 2026
Sequential BV-AVD Therapy in Richter Transformation: Insights Into the Management of Elderly PatientsArianna Bevilacqua, Alessandro Cellini, Nicolò Danesin, et al.
Pageof 20

Showing results (51-60 of 193) with videos related to

Sort By:
Pageof 20
Haematologica|December 9, 2016
Peripheral neuropathies in chronic lymphocytic leukemia: a single center experience on 816 patientsChiara Briani, Andrea Visentin, Alessandro Salvalaggio, et al.
Annals of Hematology|May 6, 2018
Splenic marginal zone lymphoma with a de novo t(8;14)(q24;q32) and a prolymphocytoid evolution responsive to rituximab-bendamustineGreta Scapinello, Marco Pizzi, Stefania Vio, et al.
Hematological Oncology|August 16, 2018
Dabigatran in ibrutinib-treated patients with atrial fibrillation and lymphoproliferative diseases: Experience of 4 casesAndrea Visentin, Elena Campello, Edoardo Scomazzon, et al.
Current Oncology (Toronto, Ont.)|March 24, 2022
Primary Myelofibrosis Occurring during Targeted Therapy for Chronic Lymphocytic Leukemia: A Report of Two CasesFrancesco Angotzi, Andrea Visentin, Federico Scarmozzino, et al.
Frontiers in Oncology|April 8, 2022
Glycerophosphoinositol Promotes Apoptosis of Chronic Lymphocytic Leukemia Cells by Enhancing Bax Expression and ActivationGioia Boncompagni, Alessia Varone, Vanessa Tatangelo, et al.
Frontiers in Oncology|July 18, 2022
p66Shc Deficiency in Chronic Lymphocytic Leukemia Promotes Chemokine Receptor Expression Through the ROS-Dependent Inhibition of NF-κBVanessa Tatangelo, Gioia Boncompagni, Nagaja Capitani, et al.
Frontiers in Oncology|April 29, 2024
Efficacy and safety of venetoclax plus hypomethylating agents in relapsed/refractory acute myeloid leukemia: a multicenter real-life experienceFrancesco Angotzi, Federica Lessi, Matteo Leoncin, et al.
Hematological Oncology|July 4, 2023
The added value of karyotype in predicting the need for therapy in chronic lymphocytic leukemia with 13q deletionAnnalisa Martines, Angela Grassi, Andrea Visentin, et al.
Haematologica|April 8, 2017
Role of <i>miR-15a/miR-16-1</i> and the <i>TP53</i> axis in regulating telomerase expression in chronic lymphocytic leukemiaEnrica Rampazzo, Engin Bojnik, Livio Trentin, et al.
Hematological Oncology|May 13, 2026
Sequential BV-AVD Therapy in Richter Transformation: Insights Into the Management of Elderly PatientsArianna Bevilacqua, Alessandro Cellini, Nicolò Danesin, et al.
Pageof 20